CompletedPhase 4

Evaluation of Eflornithine on Facial and Forearm Skin

78 participantsStarted 2004-11-30

Plain-language summary

The purpose of this study is to evaluate whether regular use of eflornithine 11.5% cream in treating women with facial hair will induce skin damage (atrophy) on the face and/or forearms

Who can participate

Age range18 Years – 85 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female subjects with clinical diagnosis of facial hirsutism/excessive facial hair * Women of childbearing potential must agree to use an effective form of birth control for the duration of the study * Skin type I-IV * Customary frequency of removal of facial hair two or more times per week Exclusion Criteria: * Pregnant or lactating women * Severe inflammatory acne or presence of significant scarring on the face * History of skin malignancy * Connective tissue disorders

What they're measuring

Change in facial skin thickness measured by ultrasound at 24 weeks

Trial details

NCT IDNCT00152048

SponsorAllergan

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Hirsutism trials